期刊
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
卷 42, 期 11, 页码 1168-1177出版社
WILEY-BLACKWELL
DOI: 10.1111/1440-1681.12465
关键词
FTY720; innate immune system; myocardial infarction; myocardial ischemia reperfusion injury; post-conditioning; sphingosine-1-phosphate; splenectomy
资金
- BONFOR-scholarship
The pathogenesis of myocardial ischemia-reperfusion injury (MI/R) involves an inflammatory response in the myocardium undergoing reperfusion. Modulation of this response by splenectomy constitutes an option to protect the heart from MI/R. To mimic the effect of splenectomy in a pharmacological approach, the sphingosine-1-phosphate agonist FTY720 was applied at the onset of reperfusion. In a closed chest model of MI/R, infarct size was assessed by triphenyltetrazolium chloride staining after 1h of ischemia and 24h of reperfusion, and by Masson trichrome staining 21days after reperfusion in splenectomised mice, mice post-conditioned with FTY720 IP (1mg/kg), and controls. In addition, hemodynamic parameters were recorded after 24h and 21days by catheterization. Infarct size, and immune cell invasion of phagocytic monocytes investigated by FACS after 24h of reperfusion were significantly reduced by both splenectomy, and FTY720 treatment. Evaluation after 21days of reperfusion revealed that FTY720 treated animals had an improved hemodynamic outcome compared to placebo treated as well as splenectomised animals. FTY720 treatment reduced cell injury as effectively as splenectomy by lowering the number of phagocytic monocytes invading the myocardium and ameliorated hemodynamic outcome within the first 21days.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据